<DOC>
	<DOC>NCT01548157</DOC>
	<brief_summary>The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of HCP1007 capsules and Rosuvastatin plus Omega-3.</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule</brief_title>
	<detailed_description>The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of HCP1007 capsules and Rosuvastatin plus Omega-3.</detailed_description>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male volunteers, age between 20 and 45 Informed of the investigational nature of this study and voluntarily agree to participate in this study BMI of ＞20kg/m2 and ＜26kg/m2 subject Use of any prescription medication within 14 days prior to Day 1 Use of any medication within 7 days prior to Day 1 Participation in another clinical study within 60 days prior to start of study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>HCP1007</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Omega-3</keyword>
</DOC>